As of 2026-09-17, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (22.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.17 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -632.8%.
The range of the Relative Valuation is (20.68) - (25.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 23.2x | 21.0x |
| Forward P/E multiples | 15.5x - 23.3x | 19.4x |
| Fair Price | (20.68) - (25.52) | (22.22) |
| Upside | -595.9% - -712.0% | -632.8% |
| Date | P/E |
| 2026-09-16 | -3.79 |
| 2026-09-15 | -3.75 |
| 2026-09-14 | -3.96 |
| 2026-09-11 | -4.02 |
| 2026-09-10 | -4.08 |
| 2026-09-09 | -4.25 |
| 2026-09-08 | -4.39 |
| 2026-09-04 | -4.47 |
| 2026-09-03 | -4.43 |
| 2026-09-02 | -4.70 |
| 2026-09-01 | -5.17 |
| 2026-08-31 | -5.22 |
| 2026-08-28 | -5.45 |
| 2026-08-27 | -5.65 |
| 2026-08-26 | -6.08 |
| 2026-08-25 | -6.23 |
| 2026-08-24 | -6.25 |
| 2026-08-21 | -6.43 |
| 2026-08-20 | -6.37 |
| 2026-08-19 | -6.42 |
| 2026-08-18 | -6.14 |
| 2026-08-17 | -6.13 |
| 2026-08-14 | -5.69 |
| 2026-08-13 | -5.90 |
| 2026-08-12 | -6.04 |
| 2026-08-11 | -5.99 |
| 2026-08-10 | -5.67 |
| 2026-08-07 | -5.52 |
| 2026-08-06 | -5.06 |
| 2026-08-05 | -4.44 |
| 2026-08-04 | -4.42 |
| 2026-08-03 | -4.19 |
| 2026-07-31 | -4.12 |
| 2026-07-30 | -4.31 |
| 2026-07-29 | -4.31 |
| 2026-07-28 | -4.66 |
| 2026-07-27 | -4.73 |
| 2026-07-24 | -4.41 |
| 2026-07-23 | -4.61 |
| 2026-07-22 | -4.74 |
| 2026-07-21 | -4.69 |
| 2026-07-20 | -4.72 |
| 2026-07-17 | -4.72 |
| 2026-07-16 | -4.61 |
| 2026-07-15 | -4.95 |
| 2026-07-14 | -4.89 |
| 2026-07-13 | -4.95 |
| 2026-07-10 | -5.41 |
| 2026-07-09 | -5.46 |
| 2026-07-08 | -5.61 |